We acknowledge that the relatively small number of PD-L1 positive cases, especially RCC, may limit the evaluation of RNA-seq as a predictive assay for the tumor types evaluated, but ORR for patients stratified by PD-L1 IHC levels was consistent with previously published values. This evidence concerns the gene CD274 and neoplasm.